Cancer is still a major global health problem. In the U.S. alone, more than 600,000 people die from cancer each year, even though over $20 billion per year is spent on research. The most advanced cancer treatments cost more than $400,000, which is not affordable for the average person. To make things worse, the cost and time of drug development is only increasing, which means these issues will not be solved soon.
We are pioneering
a platform for making artificial viruses
as precision cancer therapies
Viruses are the most abundant biological entity on earth, and have broad utility in research and medical applications. Some are even known to kill cancer cells, these are called oncolytic viruses.
To make the best possible oncolytic viruses, we will design them on a computer, synthesize the DNA and then assemble them.
Computer aided design
Assemble and test
What we do
We identify the unique aspects of each type of cancer using next-generation sequencing. Next, we use our proprietary design software and digital library to engineer an oncolytic virus that is tailor-made for this type of cancer. We then use state-of-the-art DNA synthesis and laboratory robotics to physically build the oncolytic viruses. Finally, we test our therapies, so we know they are safe and they work.
We envision a world where cancer therapies are available for everyone at an affordable price. With our platform, we believe we can make that a reality.
Our initial efforts are focused on cancer therapeutics for dogs. We believe focusing on dogs enables us to validate our technology much faster. After validating our technology, we will pursue the development of oncolytic virus therapies for humans.